EZH2, a unique marker of malignancy in effusion cytology.
about
Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array.EZH2 is a sensitive marker of malignancy in salivary gland tumors.The importance of EZH2 and MOC-31 expression in the differential diagnosis of benign and malignant effusions.EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling.Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran.
P2860
EZH2, a unique marker of malignancy in effusion cytology.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
EZH2, a unique marker of malignancy in effusion cytology.
@ast
EZH2, a unique marker of malignancy in effusion cytology.
@en
EZH2, a unique marker of malignancy in effusion cytology.
@nl
type
label
EZH2, a unique marker of malignancy in effusion cytology.
@ast
EZH2, a unique marker of malignancy in effusion cytology.
@en
EZH2, a unique marker of malignancy in effusion cytology.
@nl
prefLabel
EZH2, a unique marker of malignancy in effusion cytology.
@ast
EZH2, a unique marker of malignancy in effusion cytology.
@en
EZH2, a unique marker of malignancy in effusion cytology.
@nl
P2093
P2860
P356
P1476
EZH2, a unique marker of malignancy in effusion cytology.
@en
P2093
Huimiao Jiang
Jonathan Somma
Raavi Gupta
P2860
P304
P356
10.1002/DC.22999
P577
2013-05-02T00:00:00Z